Harbin Honor Pharmaceutical Co., Ltd. Stock Code: 002437 Stock Abbreviation: Honor Pharmaceutical Announcement No.: 2026-016
Resolution Announcement of the Ninth Meeting of the Seventh Board of Directors
The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.
On April 14, 2026, the Board Office of Harbin Honor Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") sent the "Notice of the Seventh Board of Directors' Ninth Meeting" and related proposals to all directors via SMS and email.
The ninth meeting of the seventh Board of Directors was held in person on April 24, 2026. A total of 8 directors were eligible to attend, and 8 directors actually attended.
The convening, holding, and voting procedures of the meeting comply with the "Company Law," "Articles of Association," and "Rules of Procedure for Board Meetings," and other relevant regulations. The meeting was chaired by Ms. Shen Zhaoyu, Chairman. After careful deliberation and voting by the attending directors, the following resolutions were formed:
I. The "Proposal on the Full Text and Summary of the 2025 Annual Report" was reviewed and approved. For details, please refer to the "Summary of the 2025 Annual Report" and the "Full Text of the 2025 Annual Report" disclosed on the same day in the "China Securities Journal," "Securities Times," and the CNINFO website (http://www.cninfo.com.cn) (hereinafter referred to as the "Designated Media"). This proposal was reviewed and approved by the seventh meeting of the seventh Board of Directors' Audit Committee prior to submission to the Board. Voting results: 8 votes cast, 8 votes in favor, 0 votes against, 0 abstentions.